BioLife Solutions BLFS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $27.5M+24.7% | $18.79M+24.3% | $28.07M+31.2% | $25.42M+28.9% | $22.05M+19.6% | ||
| $10M+37.9% | —— | —— | —— | $7.25M+18.2% | ||
| $17.5M+18.2% | —— | —— | —— | $14.8M+18.2% | ||
| 63.6%-3.5pp | —— | —— | —— | 67.1%-0.8pp | ||
| $2.65M+84.2% | $699K— | $2.71M+43.1% | $2.72M+34.0% | $1.44M-30.7% | ||
| $2.53M+3.4% | $1.99M+27.3% | $2.53M+0.8% | $2.73M+10.0% | $2.44M+2.8% | ||
| $12.21M+7.5% | $10.55M-8.9% | $12.07M+29.5% | $11.4M+22.3% | $11.35M+9.2% | ||
| $85K+28.8% | $261K-72.1% | $699K+2.3% | $708K+3.7% | $66K-90.4% | ||
| $17.47M+14.2% | $0— | $28.16M+29.1% | $42.06M+100% | $15.3M-29.6% | ||
| $27K+105% | $0— | -$89K+78.7% | -$16.64M-1,174% | -$499K+84.9% | ||
| 0.1%+2.4pp | 0%— | -0.3%+1.6pp | -65.5%-58.8pp | -2.3%+15.6pp | ||
| $1.04M+52.4% | $833K+1,273% | $508K+321% | $684K+310% | $683K+588% | ||
| $1.22M+55.7% | $2.02M+2,860% | $792K+695% | $931K+122% | $784K+594% | ||
| $1.25M+338% | —— | $703K+228% | -$15.71M-183% | $285K+109% | ||
| $62K+343% | —— | $82K+203% | $126K+12,500% | $14K-17.6% | ||
| $1.19M+365% | —— | $621K+136% | -$15.84M+23.6% | -$448K+95.6% | ||
| 4.3%+6.3pp | —— | 2.2%+10.2pp | -62.3%+42.8pp | -2%+53.4pp | ||
| $0.02+100% | —— | $0.01+200% | -$15,838,000.00-185% | $0.01+100% | ||
| $0+100% | $7.54M— | $0+100% | $0+100% | -$719K+89.8% | ||
| $0.02— | —— | $0.01+125% | -$0.33+26.7% | $0.00+100% | ||
| $0.02+300% | —— | $0.01+125% | -$0.33+26.7% | -$0.01+95.5% | ||
| 49.2M+1.8% | 48.6M+5.6% | 48.7M+5.5% | 47.8M+3.9% | 48.4M+6.5% | ||
| 48.5M+2.8% | 47.8M+3.7% | 47.9M+3.8% | 47.8M+3.9% | 47.1M+3.7% | ||
| $1.04M+52.4% | $833K+1,273% | $508K+321% | $684K+310% | $683K+588% | ||
| $0.02+100% | —— | $0.01+200% | -$0.33-175% | $0.01+114% | ||
| $0.02+100% | —— | $0.01+200% | -$0.33-175% | $0.01+114% | ||
| $0+100% | —— | $0+100% | —— | -$0.01— | ||
| $1.19M+338% | —— | $621K+232% | -$15.84M-185% | $271K+108% | ||
| $180K+78.2% | $1.18M— | $284K+193% | $247K+69.2% | $101K-60.1% | ||
| $27K+105% | $0+100% | -$89K+78.7% | -$16.64M-1,174% | -$499K+84.9% | ||
| $401K+119% | $261K-69.9% | $547K-44.7% | -$15.97M-11,038% | $183K+109% | ||
| $401K+119% | $261K-69.9% | $547K-44.7% | -$15.97M-11,038% | $183K+109% | ||
| 1.5%+0.6pp | 1.4%-4.3pp | 1.9%-2.7pp | -62.8%-63.6pp | 0.8%+11.3pp | ||
| $27K+105% | $0+100% | -$89K+78.7% | -$16.64M-1,174% | -$499K+84.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioLife Solutions's revenue?
- BioLife Solutions (BLFS) generated $99.8M in revenue over the trailing twelve months, up 27.5% year over year.
- Is BioLife Solutions profitable?
- BioLife Solutions is not currently profitable: it reported a net loss of $14.5M over the trailing twelve months, a -68.7% net margin.
- What are BioLife Solutions's profit margins?
- Gross margin is 66.9% and operating margin is -16.7%, with a -68.7% net margin.
- What is BioLife Solutions's earnings per share?
- BioLife Solutions's diluted EPS over the trailing twelve months is $-0.30.
- Where does BioLife Solutions's income statement data come from?
- Every line is extracted from BioLife Solutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
